Jaguar Gene Therapy
Jim brings more than 25 years of experience directing investor relations and corporate communications programs in the biotechnology, medical technology and energy services industries.
Formerly of AveXis, InterMune, Protein Design Labs and DePuy/J&J.
This person is not in any offices
Jaguar Gene Therapy
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. Led by the former AveXis leadership team and backed by Deerfield Management, a healthcare-specific investment firm, Jaguar brings streamlined R&D, manufacturing and clinical operations to accelerate development and potential approval of therapies for severe genetic diseases.